Title : Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents.

Pub. Date : 2021 Feb

PMID : 33154093






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A BET inhibitor INCB057643 effectively inhibited cell viability and induced apoptosis in DLBCL/HGBCL cells regardless of MYC/BCL2/TP53 status. INCB-057643 MYC proto-oncogene, bHLH transcription factor Homo sapiens